Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ORPH.L Share News (ORPH)
ORPH Share
Price
ORPH Share
News
ORPH Share
Chat
ORPH Share
Trades
ORPH
Live RNS
ORPH Share
Charts
ORPH Broker
Ratings
ORPH Directors
Deals
ORPH Financial
Diary
ORPH
Fundamentals
ORPH Short
Positions
ORPH
Media
ORPH Company
Research
ORPH Company
Timeline
- There is currently no data for ORPH
ORPH.L News
UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
IN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO
IN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO
IN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut
IN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut
Open Orphan secures €900,000 contract with existing customer
(Sharecast News) - Pharmaceutical services company Open Orphan has secured a new contract win with an unnamed existing customer.
Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug
Open Orphan inks contract with AIM ImmunoTech to test Ampligen drug
AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle
AIM WINNERS & LOSERS: Evgen disappointed as SFX-01 flops study hurdle
Open Orphan subsidiary scores 'significant contract' with AIM ImmunoTech
(Sharecast News) - Clinical research organisation Open Orphan's hVIVO subsidiary has signed "a significant contract" to test AIM ImmunoTech's antivira...
Cathal Friel-led Poolbeg Pharma set to float on AIM
(Sharecast News) - Infectious disease specialist Poolbeg Pharma is to list on the London Stock Exchange's junior market, AIM, with a view to raising t...
Follow the stocks
